This is the authors' abstract. We don't add key points for this paper.
Supplementary Figure S5. Evaluation of differentially expressed genes (DEGs) and tumor infiltrating immune cells (plasma cells and B cells) in drug-treated de novo MPNSTs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kohlmeyer et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: